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Abstract 
Centromeres are chromosomal loci that drive chromosome segregation during mitosis. 
Structure and identity of centromeres are maintained epigenetically by nucleosomes 
containing the histone H3 variant CENP-A. Propagation of CENP-A chromatin is 
uncoupled from DNA replication and initiates following mitotic exit. However, the 
nature of the signal that triggers assembly of CENP-A is unknown. We now show that 
neither entry into mitosis, nor protein destruction upon mitotic exit is required for 
CENP-A assembly. Instead, direct inhibition of Cdk1 and Cdk2 activities is sufficient for 
rapid CENP-A assembly at centromeres without mitotic passage, in a manner dependent 
on the canonical CENP-A assembly factors. Our results strongly support a model in 
which the CENP-A assembly machinery is poised for activation throughout the cell cycle 
but kept in an inactive state by Cdk activity during S, G2 and M phases, ensuring tight 
coupling between DNA replication, cell division and subsequent centromere maturation. 
  
Highlights for Silva et al: 
 Onset of CENP-A assembly in G1 phase is triggered by loss of Cdk1 activity 
 Cdk1 and Cdk2 are sufficient to inhibit CENP-A assembly outside of G1 phase 
Highlights
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Introduction 
Accurate segregation of newly replicated chromosomes during mitosis is essential for 
the maintenance of genome integrity. Central to preserving fidelity of this process is the 
kinetochore which forms the attachment site for spindle microtubules and is required 
for chromosome movement and mitotic checkpoint signaling (Cheeseman and Desai, 
2008). 
 The centromere is a unique constitutive chromatin domain that assembles the 
kinetochore during mitosis and is essential for mitotic progression. Centromeres are 
propagated epigenetically, largely independent of any particular DNA sequence 
(Allshire and Karpen, 2008; Amor et al., 2004). Key to the maintenance of centromere 
identity is the specific assembly of the histone H3 variant Centromere Protein A (CENP-
A) into centromeric nucleosomes (Silva and Jansen, 2009; Black and Bassett, 2008). 
Inheritance and replication of this mark is essential to ensure epigenetic propagation of 
centromere identity. Indeed, CENP-A containing nucleosomes are extremely stable and 
maintained throughout the cell cycle, being redistributed only during S phase (Jansen et 
al., 2007; Hemmerich et al., 2008; Shelby et al., 2000; Régnier et al., 2005). Importantly, 
centromeric chromatin replication is uncoupled from centromeric DNA replication and, 
at least in metazoans is restricted to late mitosis / early G1 phase of the cell cycle 
(Jansen et al., 2007; Schuh et al., 2007; Hemmerich et al., 2008). Assembly strictly 
depends on passage through mitosis (Jansen et al., 2007; Schuh et al., 2007) which 
ensures tight coupling of centromere duplication to cell cycle progression. However, the 
mitotic trigger that initiates centromere propagation has not been identified. Possible 
candidates for this have been previously proposed (Figure 1A), including changes in 
chromatin architecture (Jansen et al., 2007; Mellone and Allshire, 2003), APC-mediated 
destruction of a specific inhibitor of CENP-A assembly (Erhardt et al., 2008), or 
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assembly of a proper kinetochore-microtubule interface (Allshire and Karpen, 2008; 
Jansen et al., 2007). Here, we sought to identify the molecular signal that temporally 
controls CENP-A assembly. Our results point to a simple mechanism that excludes the 
need for any active involvement of mitosis in subsequence CENP-A assembly, other than 
the concomitant down regulation of Cdk activity upon mitotic exit. 
 
Results 
CDK inhibition is sufficient to induce CENP-A assembly 
In order to identify the molecular mechanism controlling the unusual timing of CENP-A 
assembly, we employed SNAP-based quench-chase-pulse labeling [see Methods and 
(Jansen et al., 2007)] to uniquely and directly track the fate of nascent proteins. One  
defining feature of mitotic exit is APC mediated destruction of cyclin B and concomitant 
loss of associated cyclin dependent kinase (Cdk1) activity. We therefore hypothesized 
that the CENP-A assembly process might be controlled directly by Cdk activity, without 
a strict need for APC activation, destruction of APC targets apart from the Cdk activator 
cyclin B, or any other aspect of mitosis. To test this hypothesis, we synchronized HeLa 
cells in G2 phase, upon which a nascent pool of CENP-A-SNAP, synthesized during the 
preceding S phase, was fluorescently pulse labeled. A brief (1 hour) treatment with the 
pan-Cdk inhibitors Roscovitine or Purvalanol A induced assembly in nearly half the G2 
population whereas assembly in G2 phase is never observed in control cells in which 
the nascent pool remained diffusely nuclear (Figures 1B, C, and S1A-C). Assembly under 
these transiently induced conditions in G2 phase resulted in stable incorporation of 
CENP-A into chromatin, as it is retained at centromeres on condensed mitotic 
chromosomes following Roscovitine washout (Figure S2). However, a brief, 1 hour 
induction of CENP-A assembly in this phase is likely incomplete as normal CENP-A 
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accumulation at centromeres continues for the duration of G1 phase [~10 hours 
(Lagana et al., 2010)]. 
Roscovitine treatment of G2 cells did not change cell cycle position as treatment 
prevents mitotic entry and cyclin B levels remained high (Figures 1B and S1D). 
Preservation of high cyclin B levels suggests that Roscovitine treated cells do not enter a 
precocious G1-like state by premature activation of APC mediated protein destruction. 
Indeed, blocking global proteolysis by the proteasome inhibitor MG132 did not interfere 
with G2 induced CENP-A assembly. Similarly, treatment with Cycloheximide shows that 
de novo synthesis of proteins is not required for unscheduled CENP-A loading (Figures 
1D and E). These results argue against a role for APC-mediated destruction of a putative 
inhibitor of CENP-A assembly other than the Cdk activator cyclin B. 
 
Unscheduled CENP-A assembly requires the canonical assembly factors 
We next determined whether unscheduled CENP-A assembly induced in G2 phase 
resulted from the activation of the canonical CENP-A assembly pathway. Mis18α, 
Mis18β and the Myb-domain containing protein HsKNL2/M18BP1 are essential for 
CENP-A assembly in G1 phase and are recruited to centromeres during anaphase, just 
prior to the onset of CENP-A assembly (Silva and Jansen, 2009; Fujita et al., 2007; 
Maddox et al., 2007). Strikingly, inhibition of Cdk activity in G2 cells resulted in rapid 
recruitment of GFP-Mis18α and HsKNL2/M18BP1 to centromeres (Figures 2A, B, and 
S3). Cells displayed either centromere localized GFP-Mis18α alone (Figure 2A, red 
arrow) or both GFP-Mis18α and nascent CENP-A-SNAP (Figure 2A, green arrow) but 
never CENP-A-SNAP alone (Figure 2B). This suggests that, as for canonical G1 loading of 
CENP-A, Mis18α arrives prior to, and is required for subsequent CENP-A assembly 
under induced conditions in G2 phase. Consistently, depletion of Mis18α, 
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HsKNL2/M18BP1 or the CENP-A specific chaperone HJURP (Dunleavy et al., 2009; Foltz 
et al., 2009) by siRNA treatment resulted in a reduction of both G1 phase assembly of 
nascent CENP-A as well as unscheduled assembly in G2 phase (Figure 2C). 
 
Cdk1 and Cdk2 are sufficient to maintain cell cycle control of CENP-A assembly 
Our small molecule inhibitor experiments indicate that prior to mitosis, the CENP-A 
assembly machinery is present but kept in an inactive state by Cdk activity. The 
predominant Cdks that are active during G2 phase are Cdk2 and Cdk1, both of which are 
naturally deactivated upon mitotic entry and mitotic exit, respectively (Pines, 2006), 
and both of which are strongly inhibited by Roscovitine and Purvalanol A (Wesierska-
Gadek and Krystof, 2009). However, due to the broad substrate specificity of pan-Cdk 
inhibitors (Wesierska-Gadek and Krystof, 2009), we cannot determine which Cdk (if 
any) is responsible for controlling CENP-A assembly. To address this directly we turned 
to chicken DT40 cells that harbor defined mutations in Cdk1 and Cdk2. We utilized cells 
that carry either a homozygous Cdk2 deletion (cdk2-/-) and/or express analogue 
sensitive Cdk1 in a homozygous cdk1 null background, which can be selectively 
inhibited by addition of the ATP analog 1NM-PP1 (cdk1as) (Hochegger et al., 2007). 
1NM-PP1 does not affect cell cycle progression of wild type DT40 cells, underscoring 
the specificity to the cdk1as mutation [data not shown and (Hochegger et al., 2007)]. 
These cells were further retrofitted to stably express subendogenous levels of SNAP-
tagged chicken CENP-A, which results in a centromeric fluorescent signal following 
pulse labeling with TMR-Star (Figure 3A).  
Assembly of nascent SNAP-CENP-A in DT40 cells occurred only in cells with low cyclin B 
levels and can be fully blocked when cells are prevented from entry into G1 by 
Nocodazole induced mitotic checkpoint arrest (Figures 3A, A´, and B). This 
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demonstrates that, like in human cells [Figure 1A and (Jansen et al., 2007; Hemmerich et 
al., 2008)] and fly embryos (Schuh et al., 2007), chicken DT40 cells assemble CENP-A at 
centromeres only upon mitotic exit. Cdk2 is non essential in DT40 cells (Hochegger et 
al., 2007) and mice (Berthet et al., 2003; Ortega et al., 2003) possibly due to 
compensation by cyclin A and E mediated Cdk1 activity (Hochegger et al., 2007; 
Santamaría et al., 2007). Consistently, timing of assembly did not change in the cdk2-/- 
mutant background (Figures 3A and B), indicating that inhibition of Cdk2 alone is not 
sufficient to induce unscheduled CENP-A assembly. To test for the involvement of Cdk1 
we synchronized cdk1as single or cdk1as/cdk2-/- double mutants in low (1 μM) levels of 
1NM-PP1. At these concentrations Cdk1 activity is sufficient to drive S phase 
progression but not high enough to allow entry into mitosis resulting in a G2 arrest. 
These cells were either maintained in G2 in low inhibitor concentrations, or released 
into G1 phase by inhibitor removal, or shifted to high (10 μM) doses of ATP analogue to 
completely abolish Cdk1activity. While CENP-A assembly in G1 was normal in cells of 
either genotype that were released from the G2 arrest, cdk1as single mutants showed 
little centromere assembly in G2 (Figures 3C´ and D). Strikingly, G2 arrested 
cdk1as/cdk2-/- double mutants readily incorporated CENP-A at centromeres in virtually 
all cells in both low and high 1NM-PP1 concentrations (Figures 3C and D). Clearly, loss 
of both Cdk1 and Cdk2 is sufficient to induce premature CENP-A loading, which 
indicates these activities are responsible for suppressing the CENP-A assembly 
machinery prior to mitotic exit. 
 
CENP-A assembly can be induced in S phase 
Assembly of CENP-A occurs even at low doses of 1NM-PP1 in cdk1as/cdk2-/- cells which 
maintain sufficient Cdk1 activity to progress through S phase [Figure S4A and 
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(Hochegger et al., 2007)]. This suggests different thresholds of Cdk activity for the 
inhibition of CENP-A loading and initiation of DNA replication and that unperturbed 
assembly can occur as late as early S phase (Figure 4D). Consistent with this notion, 
quantitative live cell measurements have recently shown that CENP-A assembly in 
human cells continues until ~10 hours after anaphase which is consistent with early S 
phase (Lagana et al., 2010). Cdk1/2 double inactivation in randomly cycling cells 
resulted in CENP-A assembly in ~80% of the cells (Figures 4A and S4B). The FACS 
profile in these experiments indicates that approximately 30% of cells are in S phase. 
This suggests that loss of Cdk activity leads to CENP-A assembly not only during G1 and 
G2 phases, but possibly also in S phase. To directly test this possibility, we synchronized 
cdk1as/cdk2-/- cells in S phase with hydroxyurea (HU) and assayed a nascent CENP-A-
SNAP pool in these cells. ~25% of the cells with active Cdk1 (no 1NM-PP1) assembled 
CENP-A. This likely represents cells in early S phase, which have low Cdk1 activity and 
may therefore be intrinsically competent for assembly. Inhibition of Cdk1 activity in 
cdk1as/cdk2-/- cells arrested throughout S phase induced CENP-A assembly in the 
majority of cells (~70%). This demonstrates that Cdk mediated inhibition of CENP-A 
assembly is maintained not only in G2 but also in S phase cells, which are otherwise 
competent for assembly (Figures 4B and S4C). We further validated this result by 
allowing cells to proceed into S phase in the presence of BrdU (to label DNA synthesis 
prior to 1NM-PP1 mediated induction of CENP-A assembly) confirming cell cycle 
position of these cells (Figure 4C). 
 
Discussion 
Our combined results demonstrate that the CENP-A assembly machinery is present and 
poised for activity throughout most of the cell cycle, but is kept in an inactive state by 
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Cdk1 and Cdk2 activities until completion of DNA replication and chromosome 
segregation. We further demonstrate that the only aspect of mitotic passage that is 
essential for subsequent CENP-A assembly is the resulting loss of mitotic Cdk activity. 
Because APC-mediated destruction of proteins, other than the Cdk1 activator Cyclin B, is 
not required for CENP-A assembly we argue that the trigger initiating assembly likely 
depends directly on a phospho-switch mediated by overlapping Cdk1 and Cdk2 kinase 
activity. 
Several implications follow from these findings. First, as outlined in Figure 4D, our 
results provide a logical explanation for the cell cycle coupling between DNA 
replication, mitosis and CENP-A assembly. The recently identified CENP-T/CENP-W 
complex specifically and functionally interacts with histone H3 containing nucleosomes 
directly adjacent to CENP-A nucleosomes (Hori et al., 2008; Ribeiro et al., 2010), 
suggesting that neighboring H3 and CENP-A nucleosomes make up an integral part of 
the centromeric complex. Importantly, such a mixed H3/CENP-A mitotic chromatin 
state can only be achieved by delaying assembly of CENP-A until after mitosis, providing 
a possible explanation for the temporal disconnect between DNA replication and CENP-
A loading. Second, since inhibition of CENP-A loading requires a higher Cdk activity 
threshold compared to S phase entry it is possible that cells are permissive for CENP-A 
assembly throughout G1 up to early S phase where cyclin A associated Cdk activity is 
still low. We propose that the Cdk mediated molecular switch that turns the CENP-A 
assembly machinery ´ON´ in early G1 and then ´OFF´ after S phase entry is one and 
same. This temporal restriction of CENP-A assembly activity during G1 may represent 
an important mechanism to maintain a proper centromere size. 
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Experimental procedures 
 
Cell lines and constructs 
HeLa cells and their derivatives were cultured in DMEM medium (Gibco) supplemented 
with 10% newborn calf serum (Gibco) at 37°C 5% CO2. A HeLa cell line stably 
expressing both CENP-A–SNAP and LAP-(GFP)-Mis18α was generated using the 
previous established stable cell line expressing CENP-A-SNAP (Jansen et al., 2007). A 
construct containing LAP-(GFP)-Mis18α (a gift from I. Cheeseman, MIT, Cambridge, MA) 
was stably integrated into this cell line via Moloney murine leukemia retroviral delivery. 
Cells stably expressing CENP-A–SNAP and LAP-(GFP)-Mis18α (referred to as GFP-
Mis18α throughout this paper) were selected by Blasticidin S (5 μg/mL; Invitrogen) and 
Puromycin (1,5 μg/mL; Calbiochem) and single-cell sorted by flow cytometry. The 
resulting monoclonal lines were expanded and selected by fluorescence microscopy. 
A 3xHA-SNAP-CENP-A construct was generated by inserting a PCR-generated fragment 
carrying the chicken CENP-A open reading frame (Gift from T. Fukagawa, NIG, Mishima, 
Japan) flanked by BamHI and XbaI sites into corresponding sites of pSS26m (Covalys) 
containing an additional triple HA tag at its N-terminus. The resulting 3xHA-SNAP-
CENP-A fusion protein (referred to as SNAP-CENP-A throughout this paper) was 
subcloned into p3XFLAG-CMV-14 (Sigma) (including a STOP codon, excluding FLAG 
from the ORF). DT40 cell lines were cultured in RPMI1640 medium (Gibco) 
supplemented with 50 μM β-mercaptoethanol, 10% fetal bovine serum (Gibco) and 1% 
chicken serum (Gibco) at 39°C, 5%CO2. Stable lines expressing SNAP-CENP-A were 
created in DT40 cdk1as and cdk1as/cdk2-/- backgrounds (Hochegger et al., 2007) by 
electroporation with a Gene Pulser apparatus (BioRad) at 550 V and 25 μF as described 
(Sonoda et al., 1998). Puromycin (0,5 µg/mL, Calbiochem) and Zeocin (500 µg/mL, 
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Invivogen) were used to select cdk1as and cdk1as/cdk2-/- cell lines respectively. Clonal 
lines expressing SNAP-CENP-A at sub-endogenous levels were selected by fluorescence 
microscopy after TMR-Star labeling and by western-blot using an anti-chicken CENP-A 
antibody (Gift from T. Fukagawa, NIG, Mishima, Japan). 
 
Cell synchronization and drug treatments 
HeLa cells were synchronized by a double thymidine block. Cells were treated with 
thymidine (2 mM, Sigma) for 17 h, washed twice in medium and released in medium 
containing deoxycytidine (24 µM, Sigma) for 9 h. Subsequently, cells were treated again 
with thymidine for 16h, and finally released into medium containing deoxycytidine and 
assayed. Roscovitine, Purvalanol A, MG132 and Cyclohexamide (Sigma) were used at 
100 µM, 25 µM, 24 µM, 10 µg/mL respectively. DMSO (Sigma) was used in control 
conditions.  
DT40 cells were treated with 1 µM or 10 µM of 1NM-PP1 (synthesized by Chris Larch 
and Hansjoerg Streicher, Sussex University, UK) for partial or strong inhibition of cdk1as 
activity, respectively. DT40 cells were synchronized with 100 ng/mL Nocodazole or 2 
mM Hydroxyurea (HU) (both from Sigma).  
 
SNAP quench-chase-pulse labeling 
HeLa cells expressing CENP-A-SNAP were pulse labeled by addition of 2 µM BTP 
(Covalys) in growth medium for 30 min at 37°C, 5% CO2, for irreversible, non-
fluorescent labeling of pre-existing SNAP pool . We refer to this step as “quench”. 
Following quenching, cells were chased for 6h and 30min to allow synthesis of new, 
unlabeled CENP-A-SNAP and were then pulse labeled with 2 µM TMR-Star (New 
England Biolabs) in growth medium for 15 min at 37°C, 5% CO2, thereby fluorescently 
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labeling the nascent SNAP pool, specifically. DT40 cells were quenched as described for 
HeLa cells, except that the chase time was 3h and 30 min and kept at 39 ºC and the cells 
were pulse labeled with 5 µM of TMR-Star.  
After each labeling step (both fluorescent and non-fluorescent), cells were washed twice 
with medium and reincubated at the appropriate temperature to allow excess SNAP 
substrate to be released from cells. After 30 min, cells were washed again once in 
medium. 
 
Immunofluorescence 
HeLa cells were grown on glass coverslips coated with poly-L-Lysine and fixed with 4% 
formaldehyde for 10 min. DT40 cells were resuspended in PBS at a concentration of 2 x 
105 cell/mL and cytospun at 800 rpm during 5 min. Cells were fixed with 4% 
formaldehyde for all experiments, except when staining for BrdU, in which case cells 
were fixed in MetOH/Acetone (1:1, Sigma), acid treated with 2 mM HCl during 10 min at 
RT and then washed 3 x 10 min with 100 mM Borax (Sigma). HeLa cells were stained 
with anti-CyclinB1 (1:50; sc-245, Santa Cruz), anti-CENP-T (crude serum 1:1000, gift 
from D. Foltz, University of Virginia, VA, USA) and anti-HsKNL2/M18BP1 (1 µg/mL; gift 
from P. Maddox, Université de Montréal, Montreal, Canada). DT40 cells were stained 
with anti-chicken CENP-O (1:3000; gift from T. Fukagawa, National Institute of Genetics, 
Mishima, Japan), anti-chicken CyclinB2 (1:50; gift from E. Nigg, University of Basel, 
Basel, Switzerland) and anti-BrdU (1:100; MoBU-1, Santa Cruz). Secondary antibodies 
(Cy5- or FITC-conjugated anti-mouse and FITC- or Cy3-conjugated anti-rabbit) were 
obtained from Jackson Immunoresearch Laboratories. Cells were stained with DAPI 
(Sigma) before mounting in Mowiol. 
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siRNA transfection 
All siRNAs were obtained from Dharmacon. Smart pools were used to deplete 
HsKNL2/M18BP1, HJURP and GAPDH. CENP-A and Mis18α were depleted with siRNAs: 
5'-ACAGUCGGCGGAGACAAGGdTdT-3' and 5'-CAGAAGCUAUCCAAACGUGdTdT-3' 
respectively. 60 pmoles of siRNAs were used for each depletion in 24 well format 
according to the manufacturer’s instructions. 
 
Flow cytometry 
DT40 cells (106) were harvested and fixed during 1 h at 4°C with 70% ethanol. Cells 
were washed twice in PBS containing 3% BSA (Sigma) and incubated for 3 h at RT with 
5 µg/ml propidium iodide (Sigma) and 200 µg/mL of RNaseA in PBS containing 3% BSA. 
Subsequent flow-cytometric analysis was performed on a FACScan (Becton Dickinson) 
or FACS Canto (Becton Dickinson) using CellQuest and FACSDiva software respectively. 
 
Immunoblotting 
Extracts of 105 (HeLa) or 2 x 106 (DT40) cells were separated in a 12% SDS-PAGE gel 
and transferred to a PVDF membrane. Blots were probed with anti-human-CyclinB1 (sc-
245, Santa Cruz) at a dilution of 1:500. An anti-Actin (A2066, Sigma) antibody was used 
at a dilution of 1:1000 as a loading control. To screen DT40 monoclonal lines stably 
expressing subendogenous levels of 3xHA-SNAP-CENP-A we used anti-chicken CENP-A 
(gift from T. Fukagawa, NIG, Mishima, Japan) and anti-HA (HA11, Covance Research 
Products, Inc.) antibodies at dilution of 1:3000 and 1:1000, respectively. Anti-mouse 
and anti-rabbit HRP-conjugated secondary antibodies were purchased from Jackon 
Immunoresearch Laboratories. 
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Microscopy 
Digital images were captured using a DeltaVision Core system (Applied Precision) that 
controls an inverted microscope (Olympus, IX-71), coupled to a Cascade2 EMCCD 
camera (Photometrics). 512 x 512 images were collected at 1x binning using a 100x oil 
objective (NA 1.40, UPlanSApo) with 0.2 µm z sections scanning the entire nucleus. 
Images were subsequently deconvolved and maximum signals were projected as 2D 
images using softWoRx (Applied Precision). Centromeric TMR intensity was quantified 
on non-deconvolved, maximum projection images by placing a 7 x 7 pixel square on 
each centromere using an unrelated centromere marker (CENP-T). Local background 
corrected intensity values were obtained by subtracting minimum intensity values from 
maximum values for each centromere measurement.  
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Figure legends 
Figure 1. Cdk inhibition induces premature CENP-A assembly in a proteolysis 
independent manner. (A) Schematic representing mitotic transition with key steps 
during either mitotic entry (green) or mitotic exit (red) that are potential signals for 
subsequent CENP-A assembly in early G1. (B) HeLa CENP-A-SNAP cells were 
synchronized at the G1/S boundary by double thymidine arrest. S phase synthesized 
CENP-A-SNAP was subsequently pulse labeled in G2 phase, 7 hours after release from 
thymidine. G2 cells were either mock treated (G2 control), treated with Roscovitine for 
1 hour or allowed to cycle through mitosis (G1 control) prior to fixation. Cells were 
counterstained with cyclin B and DAPI to indicate G2 status and DNA respectively. (C) 
Quantification of B. (D) Experiment as in B but with the inclusion of MG132 or 
cycloheximide to block proteolysis or protein synthesis, respectively. (E) Quantification 
of D. Mean and SEM of 3 replicates are shown in C and E. Percentage of total cells 
positive for centromeric CENP-A-SNAP (TMR-Star) signal was scored and represented 
according to cyclin B status. See also Figure S1 and S2. 
 
Figure 2. Unscheduled CENP-A assembly in G2 phase occurs through the canonical 
assembly pathway. (A) CENP-A-SNAP, GFP-Mis18α double tagged HeLa cells were 
treated as in Figure 1. G2 control or Roscovitine treated cells were counterstained for 
cyclin B to confirm G2 status and imaged to determine GFP-Mis18α and nascent CENP-
A-SNAP centromere localization. (B) Quantification of A. (C) HeLa CENP-A-SNAP cells 
were treated with siRNAs against indicated targets (GAPDH and CENP-A serve as 
negative and positive controls, respectively) followed by synchronization by double 
thymidine block. Cells were treated with Roscovitine for 1 hour in G2 to induce CENP-A 
assembly or were cycled into the next cell cycle and collected at the next G1/S boundary 
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following canonical CENP-A assembly. Cells were imaged and TMR centromere intensity 
was determined. >1200 centromeres were quantified per condition. Mean and SEM of 3 
replicates of each condition are shown in B and C. See also Figure S3. 
 
Figure 3. CENP-A assembly is suppressed by both Cdk1 and Cdk2 activity. (A) DT40 
cdk1as/cdk2-/- double mutant cells (i.e. Cdk2 null but Cdk1 WT) stably expressing SNAP-
CENP-A were assayed for assembly of a nascent pool in either asynchronous cultures or 
cells prevented from entering G1 phase by Nocodazole treatment. Blowups show 
nascent SNAP-CENP-A (TMR-Star) colocalization with centromeres (CENP-O). (A´) as A 
but for cdk1as single mutant (i.e. Cdk1 and Cdk2 WT). (B) Quantification of A and A´. 
Dotted line represents the maximally expected percentage of cells assembling CENP-A 
(3,5 hour synthesis / 8 hour cell cycle (Zhao et al., 2007) x 100 = 44%). (C) DT40 
cdk1as/cdk2-/- cells were synchronized in S/G2 phase with a low concentration (1 µM) 
of 1NM-PP1, followed by synthesis of a nascent SNAP-CENP-A pool. Cells were then 
either kept arrested in G2 with low (1µM) or high (10µM) 1NM-PP1 or released into G1 
followed by fixation and processing for imaging or FACS. CyclinB2 staining indicates G2 
phase. (C´) as C but for cdk1as single mutant cells. (D) Quantification of C and C´. Mean 
and SEM of 3 replicates of each condition are shown in B and D. 
 
Figure 4. S phase cells are competent for CENP-A assembly. (A) Asynchronous 
cultures of DT40 cdk1as/cdk2-/- SNAP-CENP-A cells were treated with 10 μM 1NM-PP1 
to induce G2 arrest. During the arrest, a nascent pool of SNAP-CENP-A was synthesized. 
Cells were then assayed for assembly and cell cycle position (FACS): No 1NM-PP1: 44% 
G1, 27% S, 26% G2; 10 μM 1NM-PP1: 29% G1, 30% S, 38% G2. Graph represents Mean 
and SEM of 3 replicates of each condition. (B) DT40 cdk1as/cdk2-/- SNAP-CENP-A cells 
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were arrested in S phase by HU treatment. A nascent SNAP-CENP-A pool was labeled in 
the presence or absence of 1NM-PP1 under continued HU arrest and scored for 
centromere assembly. Samples were collected for FACS analysis before (8h) and after 
(12h) nascent SNAP-CENP-A synthesis to monitor continued S phase arrest. (C) 
Experiment as in B except that cells were released from HU induced S phase arrest for 3 
hours in the presence of BrdU to monitor DNA replication. This was followed by 
synthesis of a new SNAP-CENP-A pool and re-arrest in HU to prevent exit from S phase. 
Cells were scored for CENP-A centromere assembly. Partial BrdU staining confirms S 
phase positioning of cells assayed for assembly. (D) Schematic outlining how 
Cdk1/Cdk2 uncouples CENP-A assembly from DNA replication and mitosis. See also 
Figure S4. 
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Figure S1. Roscovitine or Purvalanol A treatment induces CENP-A assembly in G2 
phase. (A) Nascent CENP-A-SNAP colocalizes with centromeres (CENP-T) after 
Roscovitine induced assembly in G2 phase cells. (B) Experiment as in Figure 1, except 
treatment of cells in G2 with either Roscovitine or Purvalanol A. (C) Quantification of B. 
(D) G2 phase Cyclin B levels remain unchanged in MG132 and/or Roscovitine at 
concentrations used in Figure 1D. HeLa CENP-A-SNAP cells were synchronized in G2 by 
release from a double thymidine block followed by a 1 hour treatment with indicated 
drugs. Cells were processed for immunoblot and probed for Cyclin B1 levels or Actin (as 
a loading control) (D´), MG132 is sufficient to prevent cyclin B degradation upon mitotic 
exit. Experiment as in D except cells were arrested in mitosis by 6 hour treatment with 
nocodazole. Mitotic cells were collected by mitotic shake-off and either kept arrested, 
released into medium or medium containing MG132.  
 
Figure S2. CENP-A-SNAP assembled in G2 phase is stable during mitosis. 
Experiment as in Figure 1 except cells were released from Roscovitine after a 1 hour 
induction of CENP-A assembly in G2 phase. Cells were analyzed in mitosis (1 hour after 
washout) and scored for retention of nascent CENP-A-SNAP on mitotic chromosomes. 
 
Figure S3. Roscovitine induces premature centromere targeting of Mis18α and 
HsKNL2/M18BP1. (A) Experiment as in Figure 2 but stained using antibodies against 
endogenous HsKNL2/M18BP1. (B) Quantification of A. Number of cells analyzed is 
indicated between brackets. 
 
Supplemental Figures and Text
Figure S4. Loss of Cdk1 and 2 activities in S phase results in unscheduled CENP-A 
assembly. (A) DT40 cdk1as or cdk1as/cdk2-/- mutant cells were treated with either low 
(1 μM) or high (10 μM) 1NM-PP1 for 12 hours followed by processing for FACS. Note 
that whereas cdk1as single mutants arrest in G2 at both 1NM-PP1 concentrations used, 
cdk1as/cdk2-/- double mutants can enter S phase and progress to G2 in low but not in 
high 1NM-PP1. (B) Images of cells quantified in Figure 4A. (C) Images of cells quantified 
in Figure 4B, demonstrating centromere assembly of nascent SNAP-CENP-A during S 
phase arrest.  
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